Market News / Story
Bavarian Nordic Upgrades Full-Year 2026 Financial Guidance After Strong Travel Health Performance
GlobeNewswire ·
GlobeNewswire reports: COPENHAGEN, Denmark, October 8, 2026 – Bavarian Nordic A/S OMX:BAVA today announced an upgrade to the financial guidance for the full year 2026, reflecting stronger-than-expected performance in its Travel Health business. Revenue from Travel Health is now expected to reach approximately DKK 3,400 million, compared to previous guidance of approximately DKK 3,000 million. The increase is primarily driven by higher rabies vaccine sales, particularly in the United States,…